Influence of indapamide on pharmacokinetics of telmisartan in male and female rats

Chinese Journal of Pharmacology and Toxicology

Volumn 23, Issue 1, 2009, Pages 1-5

  Wang, Mine Xia ^a   Shan, Bao En ^a   Li, Wei Wei ^a   Wang, Min ^a   Su, Xi Gai ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Chromatography, high pressure liquid; Indapamide; Pharmacokinetics; Telmisartan

Indexed keywords

INDAPAMIDE; TELMISARTAN;

ANIMAL EXPERIMENT; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; FEMALE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; RAT; SEX DIFFERENCE; WISTAR RAT;

RATTUS; RATTUS NORVEGICUS;

EID: 61849104603     PISSN: 10003002     EISSN: None     Source Type: Journal    
DOI: 10.3867/j.issn.1000-3002.2009.01.001     Document Type: Article

References (19)

1. Wienen W, Hauel N, Van Meel JC, Narr B, Ries U, Entzeroth M. Pharmacological characterization of the novel nonpeptide angiotensin II receptor antagonist, BIBR 277 [ J ]. Br J Pharmacol, 1993, 110(1) :245 - 252.
2. Wienen W, Entzeroth M, van Meel JCA, Stangier J, Busch U, Ebner T, et al. Review on telmisartan: a novel long-acting angiotensin II receptor antagonist [ J ]. Cardiovasc Drug Rev, 2000, 18:127-156.
3. Neutel JM, Smith DHG. Dose response and antihypertensive efficacy of the ATI receptor antagonist telmisartan in patients with mild to moderate hypertension [ J ]. Adv Ther, 1998, 15: 206-217.
4. Unger T, Kaschina E. Drug interactions with angiotensin receptor blockers; a comparison with other antihypertensives [ J ]. Drug Saf, 2003, 26 (10) :707-720.
5. Neutel JM, Smith DH, Reilly PA. The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension [ J ]. Int J Clin Pract, 1999, 53(3) :175-178.
6. Smith DHG, Neutel JM, Morgenstern P. Once-daily telmisartan compared with enalapril in the treatment of hypertension[J]. Adv Ther, 1998, 15:229-240.
7. Hernández-Hernóindez R, Velasco M, Armas-Hernóindez MJ, Armas-Padilla MC. Angiotensin II receptor antagonists in arterial hypertension [ J ]. J Hum Hypertens, 2000, 14(Suppl 1):S69-S72.
8. Sassard J, Bataillard A, Mclntyre H. An overview of the pharmacology and clinical efficacy of indapamide sustained release [ J ]. Fundam Clin Pharmacol, 2005, 19(6) :637-645.
9. Mogensen CE. New treatment guidelines for a patient with diabetes and hypertension [ J ]. J Hypertens Suppl, 2003, 21(1) :S25-S30.
10. Wei B, Wang YQ, Zhou DX. Clinial efficacy of telmisartan and indapamide in treatment of mild to moderate essential hypertension [ J ]. Chin J Clin Pharm 2004, 13(5) ;267 - 269.
11. Ambrosioni E, Safar M, Degaute JP, Malin PL, Mac-Mahon M, Pujol DR, et al. Low-dose antihypertensive therapy with 1. 5 mg sustained-release indapamide: results of randomised double-blind controlled studies. European Study Group [ J ]. J Hypertens, 1998, 16 (11) :1677 - 1684.
12. Wang MX, Hou J, Wu JS, Wang M, Li WW, Zhang JZ, et al. Improvement of HPLC-fluorometric method in the determination of telmisartan in human plasma [ J ]. China Pharm, 2007, 18 ( 20 ) : 1556-1558.
13. Bornstein N, Silvestrelli G, Caso V, Parnetti L. Arterial hypertension and stroke prevention; an update [ J ]. Clin Exp Hypertens, 2006, 28(3 -4) :317 -326.
14. Zhao X, Xu JY, Liu WY. RP-HPLC determination of telmisartan in rat plasma[ J]. J China Pharm Univ 2003, 34(3) :247 - 249.
15. Tatami S, Sarashina A, Yamamura N, Igarashi T, Tan-igawara Y. Population pharmacokinetics of an angiotensin II receptor antagonist, telmisartan, in healthy volunteers and hypertensive patients [ J ]. Drug Metab Pharmacoh.net, 2003, 18(3) :203-211.
16. Tatami S, Yamamura N, Sarashina A, Yong CL, Igarashi T, Tanigawara Y. Pharmacokinetic comparison of an angiotensin II receptor antagonist, telmisartan, in Japanese and western hypertensive patients using population pharmacokinetic method [ J ]. Drug Metab Pharmacokinet, 2004, 19(1) :15 - 23.
17. Mackenzie PI, Miners JO, McKinnon RA. Polymorphisms in UDP glucuronosyltransferase genes; functional consequences and clinical relevance [ J ]. Clin Chem Lab Med, 2000, 38(9) :889-892.
18. Stangier J, Su CA, Roth W. Pharmacokinetics of orally and intravenously administered telmisartan in healthy young and elderly volunteers and in hypertensive patients [J]. J Int Med Res, 2000, 28(4) :149 - 167.
19. Stangier J, Su CA, Fraunhofer A, Tetzloff W. Pharmacokinetics of acetaminophen and ibuprofen when coadministered with telmisartan in healthy volunteers [ J ]. J Clin Pharmacol, 2000, 40; 1338 - 1346.